Food and Drug Administration

Korean chipmakers South Korea asks US for tailored approach to chip tariffs

South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Foreign exchange S.Korea plans $1.2 bn forex bond issue after presidential election

South Korea plans to issue up to $1.2 billion in foreign exchange stabilization bonds as early as June, in what would mark the new administration&rs...

Food & Beverage India: Tantalizing frontier for K-food’s global ambitions beyond China

South Korea’s processed food exports to India have surged to a record 6 trillion won ($4.1 billion), marking a significant milestone in the gr...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Mergers & Acquisitions KFC’s Korean operations up for sale

Orchestra Private Equity has begun the process of divesting the South Korean operations of fast-food chain KFC, which has seen earnings growth since...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Retail Baemin, Yogiyo see record transaction drops in Feb amid Coupang's rise

South Korea’s top and third-ranked food delivery apps, Baedal Minjok (Baemin) and Yogiyo, saw their biggest-ever monthly drops in transaction ...

Bio & Pharma SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Bio & Pharma Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Retail Coupang Eats starts food delivery service in Japan

Coupang Eats, a food delivery app operated by South Korea's No. 1 e-commerce platform Coupang Inc., launched its first overseas service in Japan.Acc...

Bio & Pharma Lotte Biologics eyes first ADC CDMO order in 2025

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Bio & Pharma SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

Korean food K-food, fashion, beauty to up ante on global push in 2025

South Korean food, beauty and fashion companies, which have enjoyed robust demand for their products in overseas markets this year, will grow bolder...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Food & Beverage S.Korea's office cafeteria firms expand into overseas markets

South Korea's office cafeteria companies, including Hyundai Green Food Co., Ourhome, and Samsung Welstory plan to expand overseas markets with the p...

Economy S.Korea-Philippines FTA to boost car and food exports

South Korea and the Philippines free trade agreement (FTA) is expected to increase exports to the Philippines, especially cars and parts, which will...

Korean food Daesang launches kimchi brand with three-Michelin-star chef

South Korean leading food maker Daesang Corp., the operator of kimchi brand Jongga, said on Thursday it launched San Ho Won with three-Michelin-star...

Food & Beverage Samyang Foods to establish overseas plant in China

South Korea's Samyang Foods Co. said on Monday it will build its first overseas plant in China. The company plans to invest 64.7 billion won ($...

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Food & Beverage Samyang Foods releases export-only ramyun brand in Thailand

South Korea's Samyang Foods Co. said on Wednesday it launched the new export-only ramyun brand Mep in Thailand. Mep is the second brand for the...

Bio & Pharma SK Biopharm submits NDA of epilepsy drug to China

South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...

Bio & Pharma Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Korean food CJ CheilJedang to invest $584 mn to build food factories in Europe, US

CJ CheilJedang Corp., South Korea’s largest food company, will spend a total of $584 million to build new food-manufacturing factories in Euro...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Mergers & Acquisitions CJ CheilJedang puts bio business on market for $4 bn

CJ CheilJedang Corp., South Korea’s largest food company, is seeking to sell its bio business for about 6 trillion won ($4.3 billion) in what ...